Atlas Trials

Effect of a Combination Oral Formulation of Hyaluronic Acid, Chondroitin Sulphate and Magnesium Trisilicate in Patients With Gastro-Esophageal Reflux Disease Not Fully Satisfied With Their Treatment

Clinical trial NCT04202692 · COMPLETED

Trial details

NCT number
NCT04202692
Sponsor
SOFAR S.p.A.
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Gastro Esophageal Reflux
Start date
2019-11-05
Primary completion
2022-11-23
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.